{
    "SPADE_N_03149": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 2003/0092612 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2003_0092612_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2003-5-15",
                "Family Info": "CA2451469A1,EP1406647A1,EP1406647A4,US6872705,WO2003006046A1",
                "Patent Title": "Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions.",
                "Abstract": "Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
            },
            {
                "Patent No": "US 6872705 B2",
                "Patent Link": "http://www.lens.org/lens/patent/US_6872705_B2",
                "Patent Type": "Granted Patent",
                "Publication Date": "2005-3-29",
                "Family Info": "US4525346,US6372234,US6482799",
                "Patent Title": "Use Of Antimicrobial Peptides As Preservatives In Ophthalmic Preparations, Including Solutions, Emulsions, And Suspensions",
                "Abstract": "Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially nonoxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_03149",
            "Peptide Name": "Neutrophil defensin 2 (HNP-2, HP-2, HP2; Human, mammals, animals)",
            "Source": "Homo sapiens (Human)",
            "Family": "Belongs to the alpha-defensin family",
            "Gene": "DEFA1 AND DEFA1B",
            "Sequence": "CYCRIPACIAGERRYGTCIYQGRLWAFCC",
            "Sequence Length": 29,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P59665",
                "http://www.uniprot.org/uniprot/P11479",
                "http://www.uniprot.org/uniprot/Q14125",
                "http://www.uniprot.org/uniprot/Q6EZF6",
                "http://www.uniprot.org/uniprot/P59666",
                "http://www.uniprot.org/uniprot/P11479",
                "http://www.uniprot.org/uniprot/Q14125"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Antiviral(SARS-CoV-2)"
            ],
            "Target Organism": "[Ref.34206990]Virus:SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(approximately 50% inbibition at 1 μg/mL (290 nM)).Gram-negative bacteria:Escherichia coli ATCC 8739 (vLD50=3.5±0.79 µg/ml), E. coli ATCC 25922 (vLD50=3.5±0.6 µg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=16±4.0 µg/ml);Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (vLD50=4.2±0.9 µg/ml), S. aureus ATCC 29213 (vLD50=2.4±0.3 µg/ml), Bacillus cereus ATCC 10876 (vLD50=0.22±0.04 µg/ml).(Ref.2)NOTE:vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Cyclic",
            "N-terminal Modification": "No specific N-terminal",
            "C-terminal Modification": "No specific C-terminal",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C147H223N43O37S6",
            "Mass": 3377.0,
            "PI": 8.67,
            "Net Charge": 3,
            "Hydrophobicity": 0.25,
            "Half Life": "Mammalian:1.2 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Defensin 2 have antibiotic, fungicide and antiviral activities. Has antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane.",
            "PTM": "Contains three disulfide bonds 1-29; 3-18; 8-28.",
            "Literature": [
                {
                    "Title": "Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.",
                    "Pubmed ID": "34206990",
                    "Reference": "Viruses. 2021 Jun 26;13(7)1246.",
                    "Author": "Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=34206990"
                },
                {
                    "Title": "Antibacterial activity and specificity of the six human {alpha}-defensins.",
                    "Pubmed ID": "15616305",
                    "Reference": "Antimicrob Agents Chemother. 2005 Jan;49(1)269-275.",
                    "Author": "Ericksen B, Wu Z, Lu W, Lehrer RI.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15616305"
                },
                {
                    "Title": "Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids.",
                    "Pubmed ID": "15894545",
                    "Reference": "J Biol Chem. 2005 Sep 23;280(38)32921-9.",
                    "Author": "Xie C, Prahl A, Ericksen B, Wu Z, Zeng P, Li X, Lu WY, Lubkowski J, Lu W.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15894545"
                }
            ],
            "Frequent Amino Acids": "CRA",
            "Absent Amino Acids": "DHKMNOSUV",
            "Basic Residues": 4,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 13,
            "Polar Residues": 18,
            "Positive Residues": 4,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_03110",
                    "Similarity": 1.0,
                    "Sequence": "DIPEVVVSLAWDESLAPKHPGSRKNMDCYCRIPACIAGERRYGTCIYQGRLWAFCC"
                },
                {
                    "SPADE_ID": "SPADE_N_03111",
                    "Similarity": 1.0,
                    "Sequence": "DIPEVVVSLAWDESLAPKHPGSRKNMACYCRIPACIAGERRYGTCIYQGRLWAFCC"
                },
                {
                    "SPADE_ID": "SPADE_N_03148",
                    "Similarity": 1.0,
                    "Sequence": "ACYCRIPACIAGERRYGTCIYQGRLWAFCC"
                }
            ]
        }
    }
}